1 Year Total Returns (Daily) Chart

View 1 Year Total Returns (Daily) for ELTP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View 1 Year Total Returns (Daily) Chart
Start Trial

Historical 1 Year Total Returns (Daily) Data

View and export this data back to 2001. Start Trial.
Date Value
September 14, 2026 -62.83%
September 11, 2026 -61.73%
September 10, 2026 -63.42%
September 09, 2026 -62.68%
September 08, 2026 -62.52%
September 04, 2026 -63.66%
September 03, 2026 -63.10%
September 02, 2026 -60.62%
September 01, 2026 -58.50%
August 31, 2026 -58.09%
August 28, 2026 -56.16%
August 27, 2026 -49.46%
August 26, 2026 -47.95%
August 25, 2026 -48.46%
August 24, 2026 -47.33%
August 21, 2026 -46.85%
August 20, 2026 -47.21%
August 19, 2026 -46.85%
August 18, 2026 -47.13%
August 17, 2026 -43.23%
August 14, 2026 -41.49%
August 13, 2026 -32.36%
August 12, 2026 -36.62%
August 11, 2026 -36.66%
August 10, 2026 -38.37%
Date Value
August 07, 2026 -36.11%
August 06, 2026 -34.03%
August 05, 2026 -32.85%
August 04, 2026 -26.67%
August 03, 2026 -23.48%
July 31, 2026 -25.71%
July 30, 2026 -29.14%
July 29, 2026 -31.93%
July 28, 2026 -31.57%
July 27, 2026 -30.24%
July 24, 2026 -28.50%
July 23, 2026 -31.81%
July 22, 2026 -32.18%
July 21, 2026 -28.63%
July 20, 2026 -31.19%
July 17, 2026 -31.69%
July 16, 2026 -24.72%
July 15, 2026 -29.26%
July 14, 2026 -30.74%
July 13, 2026 -29.40%
July 10, 2026 -29.00%
July 09, 2026 -35.78%
July 08, 2026 -37.03%
July 07, 2026 -41.26%
July 06, 2026 -39.89%

Total Return Definition

The Total return is the change in price over a specific period of time that includes dividends and distributions paid.

Read full definition.

1 Year Total Returns (Daily) Range, Past 5 Years

View 1 Year Total Returns (Daily) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

1 Year Total Returns (Daily) Benchmarks

View 1 Year Total Returns (Daily) Benchmarks
Start Trial
Nektar Therapeutics 40.71%
Daré Bioscience, Inc. -65.10%
Eton Pharmaceuticals, Inc. 226.5%
ANI Pharmaceuticals, Inc. -27.95%
Corcept Therapeutics, Inc. 53.42%